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Objective: The study aims to assess Health Related Quality of Life (HRQoL) among Hepatitis B (HB) patients
and to identify significant predictors of the HRQoL in HB patients of Quetta, Pakistan.
Methods: A cross sectional study by adopting European Quality of Life scale (EQ-5D) for the assessment of HRQoL
was conducted. All registered HB patients attending two public hospitals in Quetta, Pakistan were approached for
study. Descriptive statistics were used to describe demographic and disease related characteristics of the patients.
HRQoL was scored using values adapted from the United Kingdom general population survey. EQ-5D scale scores
were compared with Mann–Whitney and Kruskal-Wallis test. Standard multiple regression analysis was performed
to identify predictors of HRQoL. All analyses were performed using SPSS v 16.0.
Results: Three hundred and ninety HB patients were enrolled in the study. Majority of the participants
(n = 126, 32.3%) were categorized in the age group of 18-27 years (36.07 ± 9.23). HRQoL was measured as poor in
the current study patients (0.3498 ± 0.31785). The multivariate analysis revealed a significant model (F10, 380 = 40.04,
P < 0.001, adjusted r2 = 0.401). Educational level (β= 0.399, p = 0.025) emerged as a positive predictor of HRQoL.
Age, gender, occupation, income and locality were not predictive of better quality of life in HB patients.
Conclusions: Hepatitis B has an adverse affect on patients’ well-being and over all HRQoL. The study findings
implicate the need of health promotion among HB patients. Improving the educational status and imparting
disease related information for the local population can results in better control and management of HB.
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Quality of life (QOL) includes subjective evaluation of
positive and negative aspects of life [1]. It is an indivi-
duals’ perception of their position in life within the con-
text of the culture and value systems in relation to their
goals, expectations, standards, and concerns [2]. On the
contrary, Health Related Quality of Life (HRQoL) and its
determinants encompass aspects of overall quality of life
that affect health (physical or mental) [3-6]. Therefore,
compared to QOL, HRQoL is an important tool in iden-
tifying patient's perception of being ill and the assess-
ment of treatment outcomes [7].* Correspondence: nomanhaq79@gmail.com
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reproduction in any medium, provided the orHepatitis-B (HB) is one of the most common liver
infections in the world. More than 2 billion people have
been infected by HB worldwide, and out of those, 350
million have chronic, lifelong infection. An estimated 0.6
million people die each year from HB-related liver dis-
eases and 3–4 million people are newly infected [8,9].
The development of chronic conditions with decreased
life expectancies is very disturbing for the patients [10].
The advance stage development (liver cirrhosis and
hepatocellular carcinoma), expensive treatments and fear
of death associated with HB, affects patients’ daily life
activities and results in decrease health status [11,12].
In addition, patients with HB often report decreased
HRQoL because of fatigue, loss of self-esteem, inability
to function at work, anxiety, depression, and other emo-
tional problems [13].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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countries, the very concept is often neglected when
patients are treated for chronic diseases like HB. Within
this context, Pakistan being one of the highest populated
countries in the world has more than 24% of the popula-
tion living below the national poverty line [14]. Lack of
health facilities and human recourses in health sector is
counted as a major obstacle in delivering optimal health
care to the population. In addition, uncaring inhuman
behaviour and unavailability of the doctors is another
major concern [15]. In the presence of such entities, the
healthcare is unable to provide the ‘required’ facilities
and in return affects the health status of the patients.
To the best of our knowledge, little is known about
the HRQoL status among Pakistani population suffering
from HB. Although few studies [16-18] reported HRQoL
among Pakistani population suffering from multiple liver
diseases, there is paucity of data concerning HRQoL
solely among HB patients. Therefore, this study aims
to evaluate the profile and predictors of HRQoL among
HB patients attending public hospitals in Quetta city,
Pakistan.
Methods
Study design, settings and sampling
A questionnaire based, cross sectional analysis was con-
ducted. Registered patients from two public hospitals
(Sandmen Provisional Hospital and Bolan Medical Com-
plex Hospital) of Quetta city, Pakistan were included for
the study. Both of these hospitals are tertiary care insti-
tutes and being public in nature provide treatment to
the majority of the population.
HB is reported to affect 11% of population in Pakistan
[19,20]. Therefore, a prevalence based sample of 390 HB
patients was selected for the study from March 2011 to
July 2011 [21,22]. Patients aging 18 years and above,
having confirmed diagnosis of HB, and familiar with
Urdu (National language of Pakistan) were included in
the study. Patients having co-morbidities, immigrants
from other countries and pregnant ladies were excluded.
Ethical approval
This study was performed according to the ethical stan-
dards for human experimentation [23]. The Joint Clinical
Research Committee (for Sandmen Provisional Hospital
and Bolan Medical Complex Hospital) approved the
study protocol (No.EA/NUH/1205-2009). Written consent
was also taken from the patients prior to data collection.
Patients were made sure about the confidentiality of their
responses and their right to withdraw from the study.
Study instrument
European Quality of Life scale EQ-5D was used to mea-
sure HRQoL. EQ-5D is a standardized generic HRQoLinstrument developed by the EuroQoL group. It provides
a simple descriptive summary and a single index value
for health status [24]. EQ-5D consists of five domains
(i.e. mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression) each of which can further cat-
egorized into three levels of severity (no problems/some or
moderate problems/extreme problems). Two hundred and
twenty six different health responses can be achieved de-
scribing health status of respondents. VAS (Visual ana-
logue scale) is the other portion of EQ-5D consisting of
a 20 cm health meter with two distinct end points (i.e.
100 which is the best imaginable health state and 0
which is the worst imaginable health state). It is a valid,
easy to administer, less time consuming instrument which
is available in Urdu [25]. EQ-5D is a self-administered
instrument but six pharmacists were recruited and trained
by the researcher team, to help patients having diffi-
culty in understanding the questions. This study was
registered with EuroQoL. The internal consistency and
validity of questionnaire was ensured (the Cronbach’s
alpha value being 0.65 for the instrument used in the
study) [26].
Statistical analysis
Descriptive analysis of patients’ demographic informa-
tion was performed. Categorical variables were measured
as percentages while continuous variables were expressed
as mean ± standard deviation. As general population
norms for Pakistani population are not documented,
EQ-5D was scored by using values derived from the
UK general population survey reported in 1995 [27].
Mann–Whitney and Kruskal Wallis tests were used as
Kolmogrov-Smirnov test revealed non normal distri-
bution of the data. Standard multivariate regression
analysis was applied to investigate the effects of demo-
graphic variables on HRQoL in the current cohort of HB
patients. A statistical value of P < 0.05 was taken as sig-
nificant. All analyses were performed using SPSS 16.0
(SPSS Inc., Chicago, IL).
Results
Demographic characteristics
Table 1 describes the demographic information of the
study participants. Mean age of respondents was
36.07 ± 9.23 years and the cohort was dominated by 232
(59.5%) of males. One hundred and four (26.7%) had pri-
mary level of education. One hundred and sixty two
(41.55%) were unemployed with 151 (38.7%) having no
income. Two hundred and seventy three (70%) were
having urban residency.
EQ-5D health status
A total of 41 health states were reported by the patients.
Poor HRQoL was measured as reported mean EQ-5D
Table 1 Demographic Characteristics of study
respondents (n = 390)
Description Frequency (390) Percentage



















Government Servant 33 8.5
Private Servant 111 28.5
Self Employed 84 21.5
Income
No Income * 151 38.7







*1 PKR= 0.0115527 USD.
Table 2 self-reported (EQ-5D) Health States
S No EQ-5D Frequency Percentage
1 11212 10 2.56
2 11222 11 2.82
3 12222 8 2.05
4 12321 11 2.82
5 12322 15 3.85
6 12323 8 2.05
7 12331 18 4.62
8 13223 1 0.26
9 21121 57 14.62
10 21122 8 2.05
11 21123 4 1.03
12 21132 3 0.77
13 21221 5 1.28
14 21222 63 16.15
15 21223 15 3.85
16 21232 8 2.05
17 21233 4 1.03
18 21312 8 2.05
19 21323 7 1.79
20 21332 5 1.28
21 21333 1 0.26
22 22111 1 0.26
23 22112 1 0.26
24 22113 4 1.03
25 22122 10 0.56
26 22211 4 1.03
27 22222 9 2.31
28 22232 6 1.54
29 22322 5 1.28
30 22333 9 2.31
31 23113 5 1.28
32 23122 4 1.03
33 23123 8 2.05
34 23212 7 1.79
35 23222 6 1.54
36 23223 5 1.28
37 23233 4 1.03
38 23322 8 2.05
39 31222 5 1.28
40 32113 6 1.54
41 32222 13 3.33
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and 57.12 ± 10.9 respectively. Sixty three (16.15%) re-
ported some problem in the first, third, fourth and fifth
domain, whereas no problem in the second domain as
shown in Table 2.
Two hundred and eighty three (72.6%) participants
indicated some problem in first domain (Mobility), 215
(55.1%) indicated no problem in second domain (self-
care), 186 (47.7%) indicated some problems in third do-
main (Usual Work), 288 (73.8%) indicated some pain
and discomfort in fourth domain (Pain and Discomfort)
and 213 (54.6%) reported moderate anxiety and depres-
sion in the fifth domain (Anxiety and Depression) as
shown in Table 3.Only gender was found to significantly associated with
VAS score (p = 0.014), (male 58.3 ± 10.692 and female
55.58 ± 11.002), however, there was no significant dif-
ferent between HRQoL and other study variables as
described in Table 4 and 5.
Table 4 Mean EQ-5D scores
Description N Mean EQ5D Std p Value
Score Deviation
Age* (36.62± 9.597)
18-27 85 0.3811 0.29440
28-37 125 0.3775 0.29613
38-47 136 0.3925 0.29432 0.056
48-57 35 0.2503 0.34559
58 < year 9
Gender**
Male 232 0.3636 0.31061 0.584
Female 158 0.3850 0.28596
Education*
Illiterate 19 0.3178 0.28567
Religious Only 67 0.3609 0.30195
Primary 104 0.3731 0.31979
Metric 54 0.4130 0.27255 0.613
Intermediate 67 0.3287 0.30961
Graduation 55 0.3812 0.29382
Post-Graduation 24 0.4517 0.27869
Occupation*
Unemployed 162 0.3849 0.29687
Government Servant 33 0.4340 0.32251 0.521
Private Servant 111 0.3472 0.29438
Self Employed 84 0.3565 0.30805
Income*
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analysis. Using the enter method, a significant model
emerged (F10, 380= 40.04, P < 0.001, adjusted r
2 = 0.401).
Educational level emerged as the influencing factors on
HRQoL. The multiple regression analysis also found that
age, gender, occupation, income and locality were not
significantly associated with HRQoL.
Discussion
The current study reveals poor HRQoL in HB patients.
In addition, the descriptive score was even less than the
perceived health status enlightening that actual health
condition is even worse than what was perceived by
the patients. Awan et al from their study conducted in
Sargodha, Punjab, Pakistan reported that HRQoL among
HB is poor with no relation to the demographic and dis-
ease characteristics [17]. The findings were again sup-
ported by Atiq et al in their study concerning HRQoL
in Islamabad, Pakistan [16].
The current study findings are also inline to what is
reported in studies from other part of the world. WU et al
in China reported lower HRQoL in HB patients in both
physical function and mental health [28]. Whereas,
Tan et al stated HB patients had no impairment in
physical and mental health, even though there was a sig-
nificant decrease in HRQoL [29]. Reduced HRQoL in
comparison to a healthy population was observed by
Svirtlih et al in Serbia [12]. A number of studiesTable 3 EQ-5D Domains
EQ-5D Domain Frequency Percentage
First Domain (Mobility)
No Problem in walking about 82 21.0
Some Problem in Walking about 283 72.6
Confined to bed 25 6.4
Second Domain (Self-care)
No Problem in self care 215 55.1
Some Problem in washing and dressing myself 127 32.6
wash and dress myself 48 12.3
Third Domain (Usual Work)
No Problem in performing usual activities 110 28.2
Some Problems in performing usual activities 186 47.7
Unable to perform usual activities 48 24.1
Forth Domain (Pain and Discomfort)
No pain and discomfort 45 11.5
Some pain and discomfort 288 73.8
Extreme pain and discomfort 57 14.6
Fifth Domain (Anxiety and Depression)
Not anxious or depress 97 24.9
Moderately anxious or depress 213 54.6
Extremely anxious or depress 80 20.5
Nil 151 0.3876 0.29377
< Pak Rs. 5000 51 0.3360 0.32486
5001-10000 36 0.3889 0.29434 0.652
10001-15000 81 0.3565 0.30586
>15001 71 0.3752 0.29992
Locality**
Urban 273 0.3751 0.30002 0.795
Rural 117 0.3655 0.30339
Total 390 0.3722 0.30068
* Kruskal Wallis Test.
** Mann Whitney Test.conducted in United States of America reported that HB
attribute to negative physical, social and psychological
health status even in absence of severe liver damage
[30-32]. Moreover, in a multination survey conducted
in United States, Canada, United Kingdom, Spain,
Hong Kong, and mainland China by Levy et al ac-
counted HB to reduce HRQoL in HB patients with
strong impact on HRQoL as the disease progresses [33].
HRQoL had significant relationship with gender in our
study. There are mixed results when our findings are
compared with studies of same nature. Olson et al re-
ported that less physical activities, alcohol use, depression
and gender (female) independently influence HRQoL
Table 5 Mean VAS scores
Description N Mean Std p Value
EQ VAS Deviation
Age* (39.02± 9.2)
18-27 85 56.9 11.406 0.291
28-37 125 57.4 10.475
38-47 136 58.0 10.953
48-57 35 54.2 9.997
58 < year 9 53.2 10.215
Gender**
Male 232 58.3 10.692 0.014
Female 158 55.5 11.002
Education*
Illiterate 19 53.8 8.719 0.112
Religious Only 67 55.4 10.418
Primary 104 56.4 11.525
Metric (SSC) 54 58.3 10.907
Intermediate (HSC) 67 58.6 10.321
Graduation 55 59.3 9.438
Post-Graduation 24 56.2 14.441
Occupation*
Unemployed 162 56.5 10.591 0.274
Government Servant 33 56.4 9.584
Private Servant 111 59.0 11.186
Self Employed 84 56.4 9.819
Income*
No Income 151 56.4 10.962 0.838
< Pak Rs. 5000 51 56.4 12.025
5001-10000 36 57.4 11.126
10001-15000 81 58.8 10.774
>15001 71 57.3 9.991
Locality**
Urban 273 57.6 10.906 0.227
Rural 117 56.2 10.831
Total 390 57.2 10.888
Table 6 Multivariate association between study variables
and HRQoL
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of disease, old age, gender (female), low socioeconomic
status and financial burden were important factors that
reduce HRQoL in HB patients [11]. Goins et al con-
cluded that age, sex, education, annual household in-
come, employment status, disease status, and obesity
were significant to HRQoL [35]. Lam et al reported
advanced stage of HB, bilirubin level, psychological co
morbidity, younger age and gender (female) were asso-
ciated with poorer HRQoL [36]. On the contrary, age,
disease severity, depression, financial hindrance and threat
of death were reported to negatively affect HRQoL in
HB patients [17]. Pappa et al highlighted age as the only
factor that had significant relationship with HRQoL [37].Younossi et al concluded that lower HRQoL in HB
patients is independent to all demographic characteristic
(including the gender) of the respondents [38].
In literature, the association between education and
HRQoL in chronic diseases is well known and persistent
[39,40]. In addition, significant results are presented be-
tween more and less educated groups [41]. Education is
responsible in providing a wide range of utilitarian pos-
sessions to the individual that are used to his/her health
advantage. Education also develops interest and involve-
ment of patients in improving one's own health which is
a key determinant of a successful medical treatment. It
is a common observation that better educated people
are less likely to develop chronic conditions, or are often
in the “controlled” status. In addition to pharmacother-
apy, better educated are more likely to adapt life style
modification and preventive measures which results in
an improvement of HRQoL. Cutler and Muney did re-
port that an additional four years of education lowers
five-year mortality by 1.8 percentage points, reduces the
risk of heart disease by 2.16 and the risk of diabetes by
1.3 percentage points [42]. The same applied to both
developed and developing countries worldwide where
more educated were reported to live longer with better
health conditions and status [42].
Keeping in view the treatment pattern and time period
of chronic illnesses, HB requires lifelong treatment. De-
veloping countries do face a number of challenges in
providing optimal health care to all of its population. In
Pakistan, majority of healthcare costs are paid by pa-
tients themselves, the cost of health care for chronic dis-
eases puts a significant strain on household budgets.
Being extremely expensive, people are pushed into pov-
erty because they have to pay directly for health services
thus decreasing their HRQoL [25]. In addition, lack of
basic health facilities and resources, behavioral aspects
and practices influence the patient in real-life scenario.
In return, a large number of patients tend to move to
other healthcare providers prior to consulting certified
practitioners. Prevalence of such entities affects the
HRQoL to more extent than it is believed and often
results in the development of resistance, hence increas-
ing the cost of therapies and decreasing the HRQoL.
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HB has an adverse impact of patients’ well-being and
HRQoL. This study provides baseline assessment for the
health status of HB patients and the results could be ap-
plied in clinical practice, particularly in early treatment
of HB and improving HRQoL. The study findings impli-
cate the need of health promotion among HB patients.
Improving the educational status and imparting disease
related information for the local population can results
in better control and management of HB.
Limitations
The study is as a cross sectional study on outpatients in
public hospitals that are usually approached by low to
middle income population. Whereas, the high income
group usually uses these facilities in emergency only.
Hence the results of our research may not represent the
entire population.
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